| PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes I Pal, M Mandal Acta Pharmacologica Sinica 33 (12), 1441-1458, 2012 | 191 | 2012 |
| Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma S Das, KK Dey, G Dey, I Pal, A Majumder, S MaitiChoudhury, SC Kundu, ... Public Library of Science 7 (10), e46641, 2012 | 184 | 2012 |
| Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells S Rajput, BNP Kumar, KK Dey, I Pal, A Parekh, M Mandal Life sciences 93 (21), 783-790, 2013 | 157 | 2013 |
| COVID-19 pandemic: cardiovascular complications and future implications D Bandyopadhyay, T Akhtar, A Hajra, M Gupta, A Das, S Chakraborty, ... American Journal of Cardiovascular Drugs 20, 311-324, 2020 | 143 | 2020 |
| Insights into molecular therapy of glioma: current challenges and next generation blueprint Y Rajesh, I Pal, P Banik, S Chakraborty, SA Borkar, G Dey, A Mukherjee, ... Acta pharmacologica sinica 38 (5), 591-613, 2017 | 112 | 2017 |
| Curcumin alleviates matrix metalloproteinase-3 and-9 activities during eradication of Helicobacter pylori infection in cultured cells and mice P Kundu, R De, I Pal, AK Mukhopadhyay, DR Saha, S Swarnakar PloS one 6 (1), e16306, 2011 | 97 | 2011 |
| Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy R Bharti, G Dey, I Banerjee, KK Dey, S Parida, BNP Kumar, CK Das, I Pal, ... Cancer letters 388, 292-302, 2017 | 79 | 2017 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 75 | 2018 |
| Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy S Parida, C Maiti, Y Rajesh, KK Dey, I Pal, A Parekh, R Patra, D Dhara, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (1), 3039-3052, 2017 | 70 | 2017 |
| Targeting translation of mRNA as a therapeutic strategy in cancer I Pal, M Safari, M Jovanovic, SE Bates, C Deng Current Hematologic Malignancy Reports 14, 219-227, 2019 | 42 | 2019 |
| Therapeutic implication of ‘Iturin A’for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion G Dey, R Bharti, PK Ojha, I Pal, Y Rajesh, I Banerjee, P Banik, S Parida, ... Cellular signalling 35, 24-36, 2017 | 36 | 2017 |
| S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ... Cancer gene therapy 23 (11), 382-391, 2016 | 36 | 2016 |
| Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis I Pal, Y Rajesh, P Banik, G Dey, KK Dey, R Bharti, D Naskar, ... Cancer letters 452, 254-263, 2019 | 34 | 2019 |
| GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling S Parida, I Pal, A Parekh, B Thakur, R Bharti, S Das, M Mandal Cell death & disease 7 (3), e2154-e2154, 2016 | 34 | 2016 |
| Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management Y Rajesh, A Banerjee, I Pal, A Biswas, S Das, KK Dey, N Kapoor, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (7), 1196-1209, 2019 | 31 | 2019 |
| Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach KK Dey, I Pal, R Bharti, G Dey, BNP Kumar, S Rajput, A Parekh, S Parida, ... Tumor Biology 36, 9829-9837, 2015 | 28 | 2015 |
| Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy BNP Kumar, N Puvvada, S Rajput, S Sarkar, SK Das, L Emdad, D Sarkar, ... Journal of Materials Chemistry B 3 (1), 90-101, 2015 | 28 | 2015 |
| Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma I Pal, KK Dey, M Chaurasia, S Parida, S Das, Y Rajesh, K Sharma, ... Tumor Biology 37, 6389-6402, 2016 | 20 | 2016 |
| Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma Y Rajesh, A Biswas, P Banik, I Pal, S Das, SA Borkar, H Sardana, A Saha, ... Oncotarget 11 (13), 1097, 2020 | 17 | 2020 |
| Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma I Pal, S Parida, BNP Kumar, P Banik, KK Dey, S Chakraborty, SK Bhutia, ... European journal of pharmacology 765, 217-227, 2015 | 15 | 2015 |
